Aminologics Co.,Ltd. (KOSDAQ: 074430)
South Korea
· Delayed Price · Currency is KRW 1,209.00
-50.00 (-3.97%)
Oct 11, 2024, 9:00 AM KST
Aminologics Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Other Revenue | - | - | -0 | -0 | - | - | Upgrade
|
| Revenue | 22,662 | 20,887 | 27,337 | 22,849 | 17,651 | 18,980 | Upgrade
|
| Revenue Growth (YoY) | 1.78% | -23.60% | 19.64% | 29.45% | -7.01% | 2.88% | Upgrade
|
| Cost of Revenue | 14,573 | 13,153 | 14,547 | 13,721 | 10,676 | 15,714 | Upgrade
|
| Gross Profit | 8,090 | 7,734 | 12,790 | 9,128 | 6,975 | 3,266 | Upgrade
|
| Selling, General & Admin | 4,479 | 4,527 | 5,179 | 4,255 | 3,912 | 3,516 | Upgrade
|
| Research & Development | 1,225 | 1,307 | 215.51 | 474.13 | 339.66 | 226.21 | Upgrade
|
| Other Operating Expenses | -5.91 | -8.14 | 9.56 | 16.06 | 19.89 | 17.8 | Upgrade
|
| Operating Expenses | 6,145 | 6,272 | 5,881 | 5,174 | 4,391 | 4,088 | Upgrade
|
| Operating Income | 1,945 | 1,462 | 6,908 | 3,953 | 2,584 | -822.29 | Upgrade
|
| Interest Expense | -70.05 | -57.08 | -40.01 | -30.92 | -36.32 | -39.33 | Upgrade
|
| Interest & Investment Income | 1,057 | 929.76 | 525.7 | 198.06 | 254.86 | 382.82 | Upgrade
|
| Currency Exchange Gain (Loss) | 632.25 | -75.28 | 397.24 | 465.53 | -359.73 | 135.95 | Upgrade
|
| Other Non Operating Income (Expenses) | 92.27 | 133.25 | 105.51 | -8.26 | 328.19 | -17.97 | Upgrade
|
| EBT Excluding Unusual Items | 3,657 | 2,393 | 7,897 | 4,578 | 2,771 | -360.81 | Upgrade
|
| Gain (Loss) on Sale of Investments | -964.26 | -101.82 | -659.69 | 658.99 | -696.82 | -840.03 | Upgrade
|
| Asset Writedown | - | - | -13,518 | -1,533 | - | - | Upgrade
|
| Pretax Income | 2,692 | 2,291 | -6,281 | 3,704 | 2,074 | -1,201 | Upgrade
|
| Income Tax Expense | -144.4 | -145.31 | 1,001 | -1,656 | -66 | - | Upgrade
|
| Earnings From Continuing Operations | 2,837 | 2,436 | -7,282 | 5,360 | 2,140 | -1,201 | Upgrade
|
| Net Income to Company | 2,837 | 2,436 | -7,282 | 5,360 | 2,140 | -1,201 | Upgrade
|
| Net Income | 2,837 | 2,436 | -7,282 | 5,360 | 2,140 | -1,201 | Upgrade
|
| Net Income to Common | 2,837 | 2,436 | -7,282 | 5,360 | 2,140 | -1,201 | Upgrade
|
| Net Income Growth | - | - | - | 150.46% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 87 | 88 | 88 | 88 | 88 | 88 | Upgrade
|
| Shares Outstanding (Diluted) | 87 | 88 | 88 | 88 | 88 | 88 | Upgrade
|
| Shares Change (YoY) | -1.81% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 32.60 | 27.74 | -82.91 | 61.03 | 24.37 | -13.67 | Upgrade
|
| EPS (Diluted) | 32.60 | 27.74 | -82.91 | 61.03 | 24.37 | -13.67 | Upgrade
|
| EPS Growth | - | - | - | 150.46% | - | - | Upgrade
|
| Free Cash Flow | 3,980 | -373.95 | 4,736 | 419.81 | 1,460 | 3,504 | Upgrade
|
| Free Cash Flow Per Share | 45.74 | -4.26 | 53.92 | 4.78 | 16.62 | 39.89 | Upgrade
|
| Gross Margin | 35.70% | 37.03% | 46.79% | 39.95% | 39.52% | 17.21% | Upgrade
|
| Operating Margin | 8.58% | 7.00% | 25.27% | 17.30% | 14.64% | -4.33% | Upgrade
|
| Profit Margin | 12.52% | 11.66% | -26.64% | 23.46% | 12.12% | -6.33% | Upgrade
|
| Free Cash Flow Margin | 17.56% | -1.79% | 17.32% | 1.84% | 8.27% | 18.46% | Upgrade
|
| EBITDA | 2,392 | 1,908 | 7,259 | 4,232 | 2,811 | -555.68 | Upgrade
|
| EBITDA Margin | 10.55% | 9.14% | 26.55% | 18.52% | 15.92% | -2.93% | Upgrade
|
| D&A For EBITDA | 446.51 | 446.15 | 350.84 | 278.81 | 226.97 | 266.61 | Upgrade
|
| EBIT | 1,945 | 1,462 | 6,908 | 3,953 | 2,584 | -822.29 | Upgrade
|
| EBIT Margin | 8.58% | 7.00% | 25.27% | 17.30% | 14.64% | -4.33% | Upgrade
|
| Advertising Expenses | - | 91.26 | 26.12 | 63.09 | 45.2 | 9.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.